MoneyWorks4Me

Aurobindo Pharma informs about investor grievance report

10 Apr 2017 Evaluate

Pursuant to Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Aurobindo Pharma has informed about Investor Grievance Report for the Quarter ended 31.03.2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..